APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oral Contrast Agent

Compare research editions
View pricing & licenses

Selected research

Industry Research

Oral Contrast Agent Industry Research Report 2026

19 December 2025128 pages

Choose your research edition.

Industry ResearchOral Contrast Agent Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Oral Contrast Agent Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Oral Contrast Agent Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oral Contrast Agent Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Oral Contrast Agent Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Oral Contrast Agent market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Oral Contrast Agent is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Oral Contrast Agent is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Oral Contrast Agent is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Oral Contrast Agent include Daiichi Sankyo (Japan), Bayer HealthCare (Germany), Unijules Life Sciences (India), Taejoon Pharm (South Korea), Spago Nanomedicine (Sweden), Magnus Health (India), Lantheus (US), Jodas (India) and J.B. Chemicals and Pharmaceuticals (India), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Oral Contrast Agent market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Oral Contrast Agent Market by Company

Daiichi Sankyo (Japan)

Bayer HealthCare (Germany)

Unijules Life Sciences (India)

Taejoon Pharm (South Korea)

Spago Nanomedicine (Sweden)

Magnus Health (India)

Lantheus (US)

Jodas (India)

J.B. Chemicals and Pharmaceuticals (India)

Guerbet (France)

GE Healthcare (US)

Bracco Imaging (Italy)

Oral Contrast Agent Segment by Type

Microbubble Contrast Media

Gadolinium-based Contrast Media

Iodinated Contrast Media

Barium-based Contrast Media

Oral Contrast Agent Segment by Application

Cardiovascular Disorders

Gastrointestinal Disorders

Nephrological Disorders

Neurological Disorders

Musculoskeletal Disorders

Cancer

Oral Contrast Agent Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Contrast Agent market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oral Contrast Agent and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Contrast Agent.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Oral Contrast Agent manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Oral Contrast Agent by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Oral Contrast Agent in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Oral Contrast Agent Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Oral Contrast Agent Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Oral Contrast Agent Sales Market Share by Manufacturers (2021-2026) Table 8. Global Oral Contrast Agent Revenue of Manufacturers (2021-2026) Table 9. Global Oral Contrast Agent Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Oral Contrast Agent Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Oral Contrast Agent Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Oral Contrast Agent, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Oral Contrast Agent, Product Type & Application Table 14. Global Oral Contrast Agent Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Oral Contrast Agent by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Daiichi Sankyo (Japan) Company Information Table 19. Daiichi Sankyo (Japan) Business Overview Table 20. Daiichi Sankyo (Japan) Oral Contrast Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Daiichi Sankyo (Japan) Oral Contrast Agent Product Portfolio Table 22. Daiichi Sankyo (Japan) Recent Developments Table 23. Bayer HealthCare (Germany) Company Information Table 24. Bayer HealthCare (Germany) Business Overview Table 25. Bayer HealthCare (Germany) Oral Contrast Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Bayer HealthCare (Germany) Oral Contrast Agent Product Portfolio Table 27. Bayer HealthCare (Germany) Recent Developments Table 28. Unijules Life Sciences (India) Company Information Table 29. Unijules Life Sciences (India) Business Overview Table 30. Unijules Life Sciences (India) Oral Contrast Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Unijules Life Sciences (India) Oral Contrast Agent Product Portfolio Table 32. Unijules Life Sciences (India) Recent Developments Table 33. Taejoon Pharm (South Korea) Company Information Table 34. Taejoon Pharm (South Korea) Business Overview Table 35. Taejoon Pharm (South Korea) Oral Contrast Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Taejoon Pharm (South Korea) Oral Contrast Agent Product Portfolio Table 37. Taejoon Pharm (South Korea) Recent Developments Table 38. Spago Nanomedicine (Sweden) Company Information Table 39. Spago Nanomedicine (Sweden) Business Overview Table 40. Spago Nanomedicine (Sweden) Oral Contrast Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Spago Nanomedicine (Sweden) Oral Contrast Agent Product Portfolio Table 42. Spago Nanomedicine (Sweden) Recent Developments Table 43. Magnus Health (India) Company Information Table 44. Magnus Health (India) Business Overview Table 45. Magnus Health (India) Oral Contrast Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Magnus Health (India) Oral Contrast Agent Product Portfolio Table 47. Magnus Health (India) Recent Developments Table 48. Lantheus (US) Company Information Table 49. Lantheus (US) Business Overview Table 50. Lantheus (US) Oral Contrast Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Lantheus (US) Oral Contrast Agent Product Portfolio Table 52. Lantheus (US) Recent Developments Table 53. Jodas (India) Company Information Table 54. Jodas (India) Business Overview Table 55. Jodas (India) Oral Contrast Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Jodas (India) Oral Contrast Agent Product Portfolio Table 57. Jodas (India) Recent Developments Table 58. J.B. Chemicals and Pharmaceuticals (India) Company Information Table 59. J.B. Chemicals and Pharmaceuticals (India) Business Overview Table 60. J.B. Chemicals and Pharmaceuticals (India) Oral Contrast Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. J.B. Chemicals and Pharmaceuticals (India) Oral Contrast Agent Product Portfolio Table 62. J.B. Chemicals and Pharmaceuticals (India) Recent Developments Table 63. Guerbet (France) Company Information Table 64. Guerbet (France) Business Overview Table 65. Guerbet (France) Oral Contrast Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Guerbet (France) Oral Contrast Agent Product Portfolio Table 67. Guerbet (France) Recent Developments Table 68. GE Healthcare (US) Company Information Table 69. GE Healthcare (US) Business Overview Table 70. GE Healthcare (US) Oral Contrast Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. GE Healthcare (US) Oral Contrast Agent Product Portfolio Table 72. GE Healthcare (US) Recent Developments Table 73. Bracco Imaging (Italy) Company Information Table 74. Bracco Imaging (Italy) Business Overview Table 75. Bracco Imaging (Italy) Oral Contrast Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Bracco Imaging (Italy) Oral Contrast Agent Product Portfolio Table 77. Bracco Imaging (Italy) Recent Developments Table 78. Global Oral Contrast Agent Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 79. Global Oral Contrast Agent Sales by Region (2021-2026) & (K Units) Table 80. Global Oral Contrast Agent Sales Market Share by Region (2021-2026) Table 81. Global Oral Contrast Agent Sales by Region (2027-2032) & (K Units) Table 82. Global Oral Contrast Agent Sales Market Share by Region (2027-2032) Table 83. Global Oral Contrast Agent Revenue by Region (2021-2026) & (US$ Million) Table 84. Global Oral Contrast Agent Revenue Market Share by Region (2021-2026) Table 85. Global Oral Contrast Agent Revenue by Region (2027-2032) & (US$ Million) Table 86. Global Oral Contrast Agent Revenue Market Share by Region (2027-2032) Table 87. North America Oral Contrast Agent Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 88. North America Oral Contrast Agent Sales by Country (2021-2026) & (K Units) Table 89. North America Oral Contrast Agent Sales by Country (2027-2032) & (K Units) Table 90. North America Oral Contrast Agent Revenue by Country (2021-2026) & (US$ Million) Table 91. North America Oral Contrast Agent Revenue by Country (2027-2032) & (US$ Million) Table 92. Europe Oral Contrast Agent Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 93. Europe Oral Contrast Agent Sales by Country (2021-2026) & (K Units) Table 94. Europe Oral Contrast Agent Sales by Country (2027-2032) & (K Units) Table 95. Europe Oral Contrast Agent Revenue by Country (2021-2026) & (US$ Million) Table 96. Europe Oral Contrast Agent Revenue by Country (2027-2032) & (US$ Million) Table 97. Asia Pacific Oral Contrast Agent Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 98. Asia Pacific Oral Contrast Agent Sales by Country (2021-2026) & (K Units) Table 99. Asia Pacific Oral Contrast Agent Sales by Country (2027-2032) & (K Units) Table 100. Asia Pacific Oral Contrast Agent Revenue by Country (2021-2026) & (US$ Million) Table 101. Asia Pacific Oral Contrast Agent Revenue by Country (2027-2032) & (US$ Million) Table 102. South America Oral Contrast Agent Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. South America Oral Contrast Agent Sales by Country (2021-2026) & (K Units) Table 104. South America Oral Contrast Agent Sales by Country (2027-2032) & (K Units) Table 105. South America Oral Contrast Agent Revenue by Country (2021-2026) & (US$ Million) Table 106. South America Oral Contrast Agent Revenue by Country (2027-2032) & (US$ Million) Table 107. Middle East and Africa Oral Contrast Agent Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. Middle East and Africa Oral Contrast Agent Sales by Country (2021-2026) & (K Units) Table 109. Middle East and Africa Oral Contrast Agent Sales by Country (2027-2032) & (K Units) Table 110. Middle East and Africa Oral Contrast Agent Revenue by Country (2021-2026) & (US$ Million) Table 111. Middle East and Africa Oral Contrast Agent Revenue by Country (2027-2032) & (US$ Million) Table 112. Global Oral Contrast Agent Sales by Type (2021-2026) & (K Units) Table 113. Global Oral Contrast Agent Sales by Type (2027-2032) & (K Units) Table 114. Global Oral Contrast Agent Sales Market Share by Type (2021-2026) Table 115. Global Oral Contrast Agent Sales Market Share by Type (2027-2032) Table 116. Global Oral Contrast Agent Revenue by Type (2021-2026) & (US$ Million) Table 117. Global Oral Contrast Agent Revenue by Type (2027-2032) & (US$ Million) Table 118. Global Oral Contrast Agent Revenue Market Share by Type (2021-2026) Table 119. Global Oral Contrast Agent Revenue Market Share by Type (2027-2032) Table 120. Global Oral Contrast Agent Price by Type (2021-2026) & (US$/Unit) Table 121. Global Oral Contrast Agent Price by Type (2027-2032) & (US$/Unit) Table 122. Global Oral Contrast Agent Sales by Application (2021-2026) & (K Units) Table 123. Global Oral Contrast Agent Sales by Application (2027-2032) & (K Units) Table 124. Global Oral Contrast Agent Sales Market Share by Application (2021-2026) Table 125. Global Oral Contrast Agent Sales Market Share by Application (2027-2032) Table 126. Global Oral Contrast Agent Revenue by Application (2021-2026) & (US$ Million) Table 127. Global Oral Contrast Agent Revenue by Application (2027-2032) & (US$ Million) Table 128. Global Oral Contrast Agent Revenue Market Share by Application (2021-2026) Table 129. Global Oral Contrast Agent Revenue Market Share by Application (2027-2032) Table 130. Global Oral Contrast Agent Price by Application (2021-2026) & (US$/Unit) Table 131. Global Oral Contrast Agent Price by Application (2027-2032) & (US$/Unit) Table 132. Key Raw Materials Table 133. Raw Materials Key Suppliers Table 134. Oral Contrast Agent Distributors List Table 135. Oral Contrast Agent Customers List Table 136. Oral Contrast Agent Industry Trends Table 137. Oral Contrast Agent Industry Drivers Table 138. Oral Contrast Agent Industry Restraints Table 139. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Oral Contrast Agent Product Image Figure 5. Global Oral Contrast Agent Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Oral Contrast Agent Market Size (2021-2032) & (US$ Million) Figure 7. Global Oral Contrast Agent Sales (2021-2032) & (K Units) Figure 8. Global Oral Contrast Agent Average Price (US$/Unit) & (2021-2032) Figure 9. Microbubble Contrast Media Product Image Figure 10. Gadolinium-based Contrast Media Product Image Figure 11. Iodinated Contrast Media Product Image Figure 12. Barium-based Contrast Media Product Image Figure 13. Cardiovascular Disorders Product Image Figure 14. Gastrointestinal Disorders Product Image Figure 15. Nephrological Disorders Product Image Figure 16. Neurological Disorders Product Image Figure 17. Musculoskeletal Disorders Product Image Figure 18. Cancer Product Image Figure 19. Global Oral Contrast Agent Revenue Share by Manufacturers in 2025 Figure 20. Global Manufacturers of Oral Contrast Agent, Manufacturing Sites & Headquarters Figure 21. Global Top 5 and 10 Oral Contrast Agent Players Market Share by Revenue in 2025 Figure 22. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Global Oral Contrast Agent Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 24. Global Oral Contrast Agent Sales by Region in 2025 Figure 25. Global Oral Contrast Agent Revenue by Region in 2025 Figure 26. North America Oral Contrast Agent Market Size by Country in 2025 Figure 27. North America Oral Contrast Agent Sales Market Share by Country (2021-2032) Figure 28. North America Oral Contrast Agent Revenue Market Share by Country (2021-2032) Figure 29. United States Oral Contrast Agent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. Canada Oral Contrast Agent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. Europe Oral Contrast Agent Market Size by Country in 2025 Figure 32. Europe Oral Contrast Agent Sales Market Share by Country (2021-2032) Figure 33. Europe Oral Contrast Agent Revenue Market Share by Country (2021-2032) Figure 34. Germany Oral Contrast Agent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. France Oral Contrast Agent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. U.K. Oral Contrast Agent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Italy Oral Contrast Agent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Netherlands Oral Contrast Agent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Asia Pacific Oral Contrast Agent Market Size by Country in 2025 Figure 40. Asia Pacific Oral Contrast Agent Sales Market Share by Country (2021-2032) Figure 41. Asia Pacific Oral Contrast Agent Revenue Market Share by Country (2021-2032) Figure 42. China Oral Contrast Agent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Japan Oral Contrast Agent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. South Korea Oral Contrast Agent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. India Oral Contrast Agent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Australia Oral Contrast Agent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. China Taiwan Oral Contrast Agent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Southeast Asia Oral Contrast Agent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Oral Contrast Agent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. South America Oral Contrast Agent Market Size by Country in 2025 Figure 51. South America Oral Contrast Agent Sales Market Share by Country (2021-2032) Figure 52. South America Oral Contrast Agent Revenue Market Share by Country (2021-2032) Figure 53. Mexico Oral Contrast Agent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Brazil Oral Contrast Agent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Argentina Oral Contrast Agent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Middle East and Africa Oral Contrast Agent Market Size by Country in 2025 Figure 57. Middle East and Africa Oral Contrast Agent Sales Market Share by Country (2021-2032) Figure 58. Middle East and Africa Oral Contrast Agent Revenue Market Share by Country (2021-2032) Figure 59. Turkey Oral Contrast Agent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Oral Contrast Agent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. UAE Oral Contrast Agent Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Global Oral Contrast Agent Sales Market Share by Type (2021-2032) Figure 63. Global Oral Contrast Agent Revenue Market Share by Type (2021-2032) Figure 64. Global Oral Contrast Agent Price (US$/Unit) by Type (2021-2032) Figure 65. Global Oral Contrast Agent Sales Market Share by Application (2021-2032) Figure 66. Global Oral Contrast Agent Revenue Market Share by Application (2021-2032) Figure 67. Global Oral Contrast Agent Price (US$/Unit) by Application (2021-2032) Figure 68. Oral Contrast Agent Value Chain Figure 69. Oral Contrast Agent Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Oral Contrast Agent Industry Opportunities and Challenges

Scope & coverage.

Types
  • Microbubble Contrast Media
  • Gadolinium-based Contrast Media
  • Iodinated Contrast Media
  • Barium-based Contrast Media
Applications
  • Cardiovascular Disorders
  • Gastrointestinal Disorders
  • Nephrological Disorders
  • Neurological Disorders
  • Musculoskeletal Disorders
  • Cancer
Companies covered
  • Daiichi Sankyo (Japan)
  • Bayer HealthCare (Germany)
  • Unijules Life Sciences (India)
  • Taejoon Pharm (South Korea)
  • Spago Nanomedicine (Sweden)
  • Magnus Health (India)
  • Lantheus (US)
  • Jodas (India)
  • J.B. Chemicals and Pharmaceuticals (India)
  • Guerbet (France)
  • GE Healthcare (US)
  • Bracco Imaging (Italy)

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Oral Contrast Agent Market Size (2021-2032)
  4. 2.2.2 Global Oral Contrast Agent Sales (2021-2032)
  5. 2.2.3 Global Oral Contrast Agent Market Average Price (2021-2032)
  6. 2.3 Oral Contrast Agent by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Microbubble Contrast Media
  9. 2.3.3 Gadolinium-based Contrast Media
  10. 2.3.4 Iodinated Contrast Media
  11. 2.3.5 Barium-based Contrast Media
  12. 2.4 Oral Contrast Agent by Application
  13. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  14. 2.4.2 Cardiovascular Disorders
  15. 2.4.3 Gastrointestinal Disorders
  16. 2.4.4 Nephrological Disorders
  17. 2.4.5 Neurological Disorders
  18. 2.4.6 Musculoskeletal Disorders
  19. 2.4.7 Cancer
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Oral Contrast Agent Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Oral Contrast Agent Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Oral Contrast Agent Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Oral Contrast Agent Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Oral Contrast Agent Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Oral Contrast Agent, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Oral Contrast Agent, Product Type & Application
  8. 3.8 Global Manufacturers of Oral Contrast Agent, Established Date
  9. 3.9 Global Oral Contrast Agent Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Daiichi Sankyo (Japan)
  2. 4.1.1 Daiichi Sankyo (Japan) Company Information
  3. 4.1.2 Daiichi Sankyo (Japan) Business Overview
  4. 4.1.3 Daiichi Sankyo (Japan) Oral Contrast Agent Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Daiichi Sankyo (Japan) Oral Contrast Agent Product Portfolio
  6. 4.1.5 Daiichi Sankyo (Japan) Recent Developments
  7. 4.2 Bayer HealthCare (Germany)
  8. 4.2.1 Bayer HealthCare (Germany) Company Information
  9. 4.2.2 Bayer HealthCare (Germany) Business Overview
  10. 4.2.3 Bayer HealthCare (Germany) Oral Contrast Agent Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Bayer HealthCare (Germany) Oral Contrast Agent Product Portfolio
  12. 4.2.5 Bayer HealthCare (Germany) Recent Developments
  13. 4.3 Unijules Life Sciences (India)
  14. 4.3.1 Unijules Life Sciences (India) Company Information
  15. 4.3.2 Unijules Life Sciences (India) Business Overview
  16. 4.3.3 Unijules Life Sciences (India) Oral Contrast Agent Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Unijules Life Sciences (India) Oral Contrast Agent Product Portfolio
  18. 4.3.5 Unijules Life Sciences (India) Recent Developments
  19. 4.4 Taejoon Pharm (South Korea)
  20. 4.4.1 Taejoon Pharm (South Korea) Company Information
  21. 4.4.2 Taejoon Pharm (South Korea) Business Overview
  22. 4.4.3 Taejoon Pharm (South Korea) Oral Contrast Agent Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Taejoon Pharm (South Korea) Oral Contrast Agent Product Portfolio
  24. 4.4.5 Taejoon Pharm (South Korea) Recent Developments
  25. 4.5 Spago Nanomedicine (Sweden)
  26. 4.5.1 Spago Nanomedicine (Sweden) Company Information
  27. 4.5.2 Spago Nanomedicine (Sweden) Business Overview
  28. 4.5.3 Spago Nanomedicine (Sweden) Oral Contrast Agent Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Spago Nanomedicine (Sweden) Oral Contrast Agent Product Portfolio
  30. 4.5.5 Spago Nanomedicine (Sweden) Recent Developments
  31. 4.6 Magnus Health (India)
  32. 4.6.1 Magnus Health (India) Company Information
  33. 4.6.2 Magnus Health (India) Business Overview
  34. 4.6.3 Magnus Health (India) Oral Contrast Agent Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Magnus Health (India) Oral Contrast Agent Product Portfolio
  36. 4.6.5 Magnus Health (India) Recent Developments
  37. 4.7 Lantheus (US)
  38. 4.7.1 Lantheus (US) Company Information
  39. 4.7.2 Lantheus (US) Business Overview
  40. 4.7.3 Lantheus (US) Oral Contrast Agent Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Lantheus (US) Oral Contrast Agent Product Portfolio
  42. 4.7.5 Lantheus (US) Recent Developments
  43. 4.8 Jodas (India)
  44. 4.8.1 Jodas (India) Company Information
  45. 4.8.2 Jodas (India) Business Overview
  46. 4.8.3 Jodas (India) Oral Contrast Agent Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Jodas (India) Oral Contrast Agent Product Portfolio
  48. 4.8.5 Jodas (India) Recent Developments
  49. 4.9 J.B. Chemicals and Pharmaceuticals (India)
  50. 4.9.1 J.B. Chemicals and Pharmaceuticals (India) Company Information
  51. 4.9.2 J.B. Chemicals and Pharmaceuticals (India) Business Overview
  52. 4.9.3 J.B. Chemicals and Pharmaceuticals (India) Oral Contrast Agent Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 J.B. Chemicals and Pharmaceuticals (India) Oral Contrast Agent Product Portfolio
  54. 4.9.5 J.B. Chemicals and Pharmaceuticals (India) Recent Developments
  55. 4.10 Guerbet (France)
  56. 4.10.1 Guerbet (France) Company Information
  57. 4.10.2 Guerbet (France) Business Overview
  58. 4.10.3 Guerbet (France) Oral Contrast Agent Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Guerbet (France) Oral Contrast Agent Product Portfolio
  60. 4.10.5 Guerbet (France) Recent Developments
  61. 4.11 GE Healthcare (US)
  62. 4.11.1 GE Healthcare (US) Company Information
  63. 4.11.2 GE Healthcare (US) Business Overview
  64. 4.11.3 GE Healthcare (US) Oral Contrast Agent Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 GE Healthcare (US) Oral Contrast Agent Product Portfolio
  66. 4.11.5 GE Healthcare (US) Recent Developments
  67. 4.12 Bracco Imaging (Italy)
  68. 4.12.1 Bracco Imaging (Italy) Company Information
  69. 4.12.2 Bracco Imaging (Italy) Business Overview
  70. 4.12.3 Bracco Imaging (Italy) Oral Contrast Agent Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Bracco Imaging (Italy) Oral Contrast Agent Product Portfolio
  72. 4.12.5 Bracco Imaging (Italy) Recent Developments
5 Global Oral Contrast Agent Market Scenario by Region
  1. 5.1 Global Oral Contrast Agent Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Oral Contrast Agent Sales by Region: 2021-2032
  3. 5.2.1 Global Oral Contrast Agent Sales by Region: 2021-2026
  4. 5.2.2 Global Oral Contrast Agent Sales by Region: 2027-2032
  5. 5.3 Global Oral Contrast Agent Revenue by Region: 2021-2032
  6. 5.3.1 Global Oral Contrast Agent Revenue by Region: 2021-2026
  7. 5.3.2 Global Oral Contrast Agent Revenue by Region: 2027-2032
  8. 5.4 North America Oral Contrast Agent Market Facts & Figures by Country
  9. 5.4.1 North America Oral Contrast Agent Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Oral Contrast Agent Sales by Country (2021-2032)
  11. 5.4.3 North America Oral Contrast Agent Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.5 Europe Oral Contrast Agent Market Facts & Figures by Country
  15. 5.5.1 Europe Oral Contrast Agent Market Size by Country: 2021 VS 2025 VS 2032
  16. 5.5.2 Europe Oral Contrast Agent Sales by Country (2021-2032)
  17. 5.5.3 Europe Oral Contrast Agent Revenue by Country (2021-2032)
  18. 5.5.4 Germany
  19. 5.5.5 France
  20. 5.5.6 U.K.
  21. 5.5.7 Italy
  22. 5.5.8 Netherlands
  23. 5.6 Asia Pacific Oral Contrast Agent Market Facts & Figures by Country
  24. 5.6.1 Asia Pacific Oral Contrast Agent Market Size by Country: 2021 VS 2025 VS 2032
  25. 5.6.2 Asia Pacific Oral Contrast Agent Sales by Country (2021-2032)
  26. 5.6.3 Asia Pacific Oral Contrast Agent Revenue by Country (2021-2032)
  27. 5.6.4 China
  28. 5.6.5 Japan
  29. 5.6.6 South Korea
  30. 5.6.7 India
  31. 5.6.8 Australia
  32. 5.6.9 China Taiwan
  33. 5.6.10 Southeast Asia
  34. 5.7 South America Oral Contrast Agent Market Facts & Figures by Country
  35. 5.7.1 South America Oral Contrast Agent Market Size by Country: 2021 VS 2025 VS 2032
  36. 5.7.2 South America Oral Contrast Agent Sales by Country (2021-2032)
  37. 5.7.3 South America Oral Contrast Agent Revenue by Country (2021-2032)
  38. 5.7.4 Mexico
  39. 5.7.5 Brazil
  40. 5.7.6 Argentina
  41. 5.8 Middle East and Africa Oral Contrast Agent Market Facts & Figures by Country
  42. 5.8.1 Middle East and Africa Oral Contrast Agent Market Size by Country: 2021 VS 2025 VS 2032
  43. 5.8.2 Middle East and Africa Oral Contrast Agent Sales by Country (2021-2032)
  44. 5.8.3 Middle East and Africa Oral Contrast Agent Revenue by Country (2021-2032)
  45. 5.8.4 Turkey
  46. 5.8.5 Saudi Arabia
  47. 5.8.6 UAE
6 Segment by Type
  1. 6.1 Global Oral Contrast Agent Sales by Type (2021-2032)
  2. 6.1.1 Global Oral Contrast Agent Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Oral Contrast Agent Sales Market Share by Type (2021-2032)
  4. 6.2 Global Oral Contrast Agent Revenue by Type (2021-2032)
  5. 6.2.1 Global Oral Contrast Agent Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Oral Contrast Agent Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Oral Contrast Agent Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Oral Contrast Agent Sales by Application (2021-2032)
  2. 7.1.1 Global Oral Contrast Agent Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Oral Contrast Agent Sales Market Share by Application (2021-2032)
  4. 7.2 Global Oral Contrast Agent Revenue by Application (2021-2032)
  5. 7.2.1 Global Oral Contrast Agent Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Oral Contrast Agent Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Oral Contrast Agent Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Oral Contrast Agent Value Chain Analysis
  2. 8.1.1 Oral Contrast Agent Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Oral Contrast Agent Production Mode & Process
  5. 8.2 Oral Contrast Agent Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Oral Contrast Agent Distributors
  8. 8.2.3 Oral Contrast Agent Customers
9 Global Oral Contrast Agent Analyzing Market Dynamics
  1. 9.1 Oral Contrast Agent Industry Trends
  2. 9.2 Oral Contrast Agent Industry Drivers
  3. 9.3 Oral Contrast Agent Industry Opportunities and Challenges
  4. 9.4 Oral Contrast Agent Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst